Our Clinical Trials
Our clinical trials are all research investigations in which people volunteer to participate to test new treatments, interventions or tests that aim to prevent, detect, treat or manage cancer. Some investigations look at how people respond to a new treatment and what side effects might occur to help determine if a new treatment works, if it is safe, and if it is better than treatments already available.
At NECTA, we value the importance of placing holistic focus on patient circumstances when considering potential early phase trials. This includes considering factors such as medical condition, living circumstances, prior treatments, as well as genetic and other biomarkers. We run a specialist early phase trials review group who meet regularly to review patient cases and provide expert input to form recommendations for treatment and trial options. The NECTA team actively considers trials across multiple locations and often refers patients between member sites, aiming to ensure the best possible option for patients, regardless of trial site.
We aim to break down barriers for patient cross referral and develop new models of care for patients with late-stage cancer. It's important to ensure patients receive access to the best available therapies regardless of their location or ethnicity, and improvements in this space need to be combined with advocacy efforts with all stakeholders. Through our initiatives we seek an improvement in the number of patients being able to access the most appropriate treatment; an increase in equity of access for treatments, with patients from varied demographics and geographies able to participate via our network of sites; and increased patient satisfaction with patient-reported outcomes.
Eligibility Criteria
Each trial is very unique in its requirements – both for the type(s) of cancer treated and the types of patients that are needed. The types of trials that NECTA specialises in are called “early phase trials” and are generally those where other standard treatment options have already been exhausted.
Participating in a Trial
If you are considering participation in a clinical trial, please consult with your doctor or oncologist about your treatment plans. NECTA welcomes enquiries from treating doctors for patients who may be suitable for participation in an early phase clinical trial. Our aim is to help find patients suitable trials across our network of treatment centres.
Partnering on a Trial
Our consortium is very open to discussing mechanisms of partnering with local, national and international hospitals in bringing cutting-edge care to all Australian cancer sufferers. We regularly interact with both pharmaceutical firms and contract research organisations to advocate for Australian cancer patients.
Information on research ethics
At NECTA, we value the importance of placing holistic focus on patient circumstances when considering potential early phase trials. This includes considering factors such as medical condition, living circumstances, prior treatments, as well as genetic and other biomarkers. We run a specialist early phase trials review group who meet regularly to review patient cases and provide expert input to form recommendations for treatment and trial options. The NECTA team actively considers trials across multiple locations and often refers patients between member sites, aiming to ensure the best possible option for patients, regardless of trial site.
We aim to break down barriers for patient cross referral and develop new models of care for patients with late-stage cancer. It's important to ensure patients receive access to the best available therapies regardless of their location or ethnicity, and improvements in this space need to be combined with advocacy efforts with all stakeholders. Through our initiatives we seek an improvement in the number of patients being able to access the most appropriate treatment; an increase in equity of access for treatments, with patients from varied demographics and geographies able to participate via our network of sites; and increased patient satisfaction with patient-reported outcomes.
Eligibility Criteria
Each trial is very unique in its requirements – both for the type(s) of cancer treated and the types of patients that are needed. The types of trials that NECTA specialises in are called “early phase trials” and are generally those where other standard treatment options have already been exhausted.
Participating in a Trial
If you are considering participation in a clinical trial, please consult with your doctor or oncologist about your treatment plans. NECTA welcomes enquiries from treating doctors for patients who may be suitable for participation in an early phase clinical trial. Our aim is to help find patients suitable trials across our network of treatment centres.
Partnering on a Trial
Our consortium is very open to discussing mechanisms of partnering with local, national and international hospitals in bringing cutting-edge care to all Australian cancer sufferers. We regularly interact with both pharmaceutical firms and contract research organisations to advocate for Australian cancer patients.
Information on research ethics
